Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2000, Vol. 22 ›› Issue (1): 8-11.

Previous Articles     Next Articles

Analyzing the mutations of rpsL gene in Mycobacterium tuberculosis clinical isolates by PCR-RFLP

WU Xueqiong,ZHANG Junxian,ZHUANG Yuhui.   

  1. Tuberculosis Research Laboratory,The 309th Hospital,Beijing 100091.
  • Received:1997-06-17 Revised:1997-11-10 Online:2000-01-10 Published:2000-01-10

Abstract: Objective To observe the mutations of rpsL gene in M.tuberculosis streptomycin-resistant isolates,and to develop a new method for detecting drug resistance.Method Analyzing the mutations of rpsL gene codon 43 in M.tuberculosis clinical isolates with PCR-RFLP.Results M.tuberculosis strain H 37 R V was used as a control.The rpsL gene fragments from 13 drug-sensitive strains could be digested by restriction endonuclease MboⅡ.31(83.8%)of 37 streptomycin resistant strains were not restricted by MboⅡ.2 of 12 non-streptomycin-resistant strains hadn't also sites of MboⅡ.Conclusions Most M.tuberculosis streptomycin-resistant strains could be observed the mutations situated at codon 43 of genes encoding the ribosomal S12 protein (rpsL).PCR-RFLP might become a simple,rapid and reliable means of detecting drug resistance in clinical isolates.

Key words: M.tuberculosis, Drug resistance polymerase chain reaction, Restriction fragment length polymorphism